RESUMO
BACKGROUND: It has been reported that retinoids may lead to hormonal alterations. AIM: In this retrospective study, we aimed to study the effect of acitretin on pituitary hormones in psoriasis patients. METHODS: Out of 50 patients intended to be studied, blood samples of 43 patients could be tested before and after 3 months of acitretin therapy (0.2 to 0.5 mg/kg/day). RESULTS: Patients mean ± standard deviation ages and female/male ratio were 46 ± 17 years and 19/24, respectively. After treatment with acitretin, gamma-glutamyltransferase, alkaline phosphatase, total cholesterol and triglyceride levels increased significantly (P < 0.05). After treatment, total protein, free thyroxine (T4) levels decreased significantly (P < 0.05). No significant differences were observed between before-after acitretin treatment regarding pituitary hormone levels in psoriasis patients (P > 0.05). LIMITATIONS: The retrospective nature of the study, inability to retest blood samples of 7 patients at 3 months post treatment, low dose and short duration of acitretin treatment were limitations of this study. CONCLUSION: This study showed that pituitary hormones were not affected except free T4 (thyroid hormone) by acitretin treatment. Further experimental and clinical studies are needed to clarify the effect of acitretin on pituitary hormones.
Assuntos
Acitretina/administração & dosagem , Ceratolíticos/administração & dosagem , Hormônios Hipofisários/sangue , Psoríase/sangue , Psoríase/tratamento farmacológico , Adulto , Relação Dose-Resposta a Droga , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Psoríase/diagnóstico , Estudos Retrospectivos , Resultado do TratamentoAssuntos
Acitretina/administração & dosagem , Anti-Inflamatórios/administração & dosagem , Clobetasol/administração & dosagem , Ceratolíticos/administração & dosagem , Doenças da Unha/diagnóstico , Doenças da Unha/tratamento farmacológico , Administração Tópica , Quimioterapia Combinada , Feminino , Humanos , Pessoa de Meia-Idade , Unhas/efeitos dos fármacos , Unhas/patologia , Resultado do TratamentoRESUMO
Acitretin, a synthetic retinoid has gradually replaced etretinate in today's dermatologic practice because of its more favorable pharmacokinetics. Acitretin over the past 20 years has proven useful in a number of difficult-to-treat hyperkeratotic and inflammatory dermatoses and nonmelanoma skin cancers. It is effective both as monotherapy and in combination with other drugs for hyperkeratotic disorders. It is considered to be an established second line treatment for psoriasis and exerts its effect mainly due to its antikeratinizing, antiinflammatory, and antiproliferative effect. Its antineoplastic properties make it a useful agent for cancer prophylaxis. Evidence-based efficacy, side-effect profile, and approach to the use of acitretin would be discussed in this review. In addition to its approved uses, the various off label uses will also be highlighted in this section. Since its use is limited by its teratogenic potential and other adverse effects, including mucocutaneous effects and hepatotoxicity, this review would summarize the contraindications and precautions to be exercised before prescribing acitretin.
Assuntos
Acitretina/administração & dosagem , Dermatologia/métodos , Ceratolíticos/administração & dosagem , Dermatopatias/tratamento farmacológico , Acitretina/farmacocinética , Animais , Antineoplásicos/administração & dosagem , Antineoplásicos/farmacocinética , Diferenciação Celular/efeitos dos fármacos , Diferenciação Celular/fisiologia , Dermatologia/tendências , Humanos , Ceratolíticos/farmacocinética , Lesões Pré-Cancerosas/patologia , Lesões Pré-Cancerosas/prevenção & controle , Absorção Cutânea/efeitos dos fármacos , Absorção Cutânea/fisiologia , Dermatopatias/patologiaRESUMO
Facial melanoses (FM) are a common presentation in Indian patients, causing cosmetic disfigurement with considerable psychological impact. Some of the well defined causes of FM include melasma, Riehl's melanosis, Lichen planus pigmentosus, erythema dyschromicum perstans (EDP), erythrosis, and poikiloderma of Civatte. But there is considerable overlap in features amongst the clinical entities. Etiology in most of the causes is unknown, but some factors such as UV radiation in melasma, exposure to chemicals in EDP, exposure to allergens in Riehl's melanosis are implicated. Diagnosis is generally based on clinical features. The treatment of FM includes removal of aggravating factors, vigorous photoprotection, and some form of active pigment reduction either with topical agents or physical modes of treatment. Topical agents include hydroquinone (HQ), which is the most commonly used agent, often in combination with retinoic acid, corticosteroids, azelaic acid, kojic acid, and glycolic acid. Chemical peels are important modalities of physical therapy, other forms include lasers and dermabrasion.
Assuntos
Dermatoses Faciais/etnologia , Dermatoses Faciais/patologia , Melanose/etnologia , Melanose/patologia , Administração Tópica , Animais , Dermatoses Faciais/terapia , Humanos , Hiperpigmentação/etnologia , Hiperpigmentação/patologia , Hiperpigmentação/terapia , Ceratolíticos/administração & dosagem , Melanose/terapia , Tretinoína/administração & dosagem , Raios Ultravioleta/efeitos adversosAssuntos
Mucinas , Nevo Sebáceo de Jadassohn/diagnóstico , Nevo Sebáceo de Jadassohn/patologia , Fatores Etários , Idoso , Feminino , Humanos , Ceratolíticos/administração & dosagem , Mucinas/análise , Nevo/diagnóstico , Nevo/tratamento farmacológico , Nevo/patologia , Nevo Sebáceo de Jadassohn/tratamento farmacológicoRESUMO
In 1937, Siemens described a Dutch family with superficial blistering, flexural hyperkeratosis, and characteristic mauserung appearance. Since then, less than 20 kindreds with this condition have been described in the English dermatologic literature. A 14-year-old boy presented with history of recurrent blistering and peeling of skin since the age of 1 month, predominantly seen over limbs and trunk, often associated with secondary infection. His mother also had similar symptoms from childhood. On examination, the child had typical mauserung peeling of the skin and dirty gray hyperkeratosis in a rippled pattern over flexures. Skin biopsy from the boy showed intracorneal blistering with epidermolytic hyperkeratosis in the upper spinous layers. The typical history and clinical features along with characteristic histological findings confirmed our diagnosis of ichthyosis bullosa of Siemens. It must be differentiated from other conditions with epidermolytic hyperkeratosis and skin peeling, such as bullous ichthyosiform erythroderma of Brocq and peeling skin syndrome. Our patient responded well to 0.05% topical tazarotene gel over four weeks.
Assuntos
Hiperceratose Epidermolítica/tratamento farmacológico , Ceratolíticos/uso terapêutico , Ácidos Nicotínicos/uso terapêutico , Dermatopatias Vesiculobolhosas/tratamento farmacológico , Administração Tópica , Adolescente , Adulto , Feminino , Géis , Humanos , Ceratolíticos/administração & dosagem , Masculino , Ácidos Nicotínicos/administração & dosagem , Resultado do TratamentoRESUMO
BACKGROUND: Chemical peeling is a skin-wounding procedure that may have some potentially undesirable side-effects. AIMS: The present study is directed towards safety concerns associated with superficial chemical peeling with salicylic acid in various facial dermatoses. METHODS: The study was a non-comparative and a prospective one. Two hundred and sixty-eight patients of either sex, aged between 10 to 60 years, undergoing superficial chemical peeling for various facial dermatoses (melasma, acne vulgaris, freckles, post-inflammatory scars/pigmentation, actinic keratoses, plane facial warts, etc.) were included in the study. Eight weekly peeling sessions were carried out in each patient. Tolerance to the procedure and any undesirable effects noted during these sessions were recorded. RESULTS: Almost all the patients tolerated the procedure well. Mild discomfort, burning, irritation and erythema were quite common but the incidence of major side-effects was very low and these too, were easily manageable. There was no significant difference in the incidence of side-effects between facial dermatoses (melasma, acne and other pigmentary disorders). CONCLUSION: Chemical peeling with salicylic acid is a well tolerated and safe treatment modality in many superficial facial dermatoses.